Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Kidney International Reports
|
June 11, 2020
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
International Journal of Nephrology and Renovascular Disease
|
April 21, 2021
Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
Myrlene Sanon Aigbogun, Dorothee Oberdhan, Michael J Doane, et al.
Pharmacoeconomics
|
March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions
Pei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 19, 2017
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument
Dorothee Oberdhan, Jason C Cole, Holly B Krasa, et al.
Kidney Medicine
|
May 1, 2024
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry
Elise Hoover, Vanessa Holliday, Nicole Merullo, et al.
Kidney Medicine
|
November 10, 2025
Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives
Belle Soyfer, Sorin Fedeles, Wendy Ruyle, et al.
Kidney International
|
August 2, 2013
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
Wendy E Boertien, Esther Meijer, Paul E de Jong, et al.
Kidney International Reports
|
May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD
Ronald D Perrone, Dorothee Oberdhan, John Ouyang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 21, 2015
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function
Wendy E Boertien, Esther Meijer, Paul E de Jong, et al.
Neurology and Therapy
|
February 15, 2023
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
Dana B DiBenedetti, Heather Menne, Russ Paulsen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Kidney International Reports
|
June 11, 2020
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
International Journal of Nephrology and Renovascular Disease
|
April 21, 2021
Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
Myrlene Sanon Aigbogun, Dorothee Oberdhan, Michael J Doane, et al.
Pharmacoeconomics
|
March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions
Pei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 19, 2017
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument
Dorothee Oberdhan, Jason C Cole, Holly B Krasa, et al.
Kidney Medicine
|
May 1, 2024
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry
Elise Hoover, Vanessa Holliday, Nicole Merullo, et al.
Kidney Medicine
|
November 10, 2025
Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives
Belle Soyfer, Sorin Fedeles, Wendy Ruyle, et al.
Kidney International
|
August 2, 2013
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
Wendy E Boertien, Esther Meijer, Paul E de Jong, et al.
Kidney International Reports
|
May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD
Ronald D Perrone, Dorothee Oberdhan, John Ouyang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 21, 2015
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function
Wendy E Boertien, Esther Meijer, Paul E de Jong, et al.
Neurology and Therapy
|
February 15, 2023
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
Dana B DiBenedetti, Heather Menne, Russ Paulsen, et al.
Page
of 4